Everolimus versus sirolimus-eluting stents for the treatment of sirolimus-eluting stent restenosis

International Journal of Cardiology

Volumn 165, Issue 3, 2013, Pages 568-569

  Yan, Rong Qiang ^a   Gao, Li Jian ^a   Chen, Ji Lin ^a  

^a FUWAI HOSPITAL   (China)

Author keywords

Everolimus eluting stents; Restenosis; Sirolimus eluting stents

Indexed keywords

ANTITHROMBOCYTIC AGENT; CREATINE KINASE MB; EVEROLIMUS; RAPAMYCIN;

ACUTE HEART INFARCTION; ADULT; ANGIOCARDIOGRAPHY; ANTICOAGULANT THERAPY; BRAIN HEMORRHAGE; BYPASS SURGERY; CONTROLLED STUDY; DEATH; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HUMAN; HYPERCHOLESTEROLEMIA; IN-STENT RESTENOSIS; INFORMED CONSENT; LETTER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STENT THROMBOSIS; AGED; BRAIN ISCHEMIA; COMPARATIVE STUDY; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; HEART DEATH; HEART INFARCTION; OUTCOME ASSESSMENT; PATIENT SAFETY; RETROSPECTIVE STUDY; THROMBOSIS;

EID: 84877076046     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.09.040     Document Type: Article

References (9)

1. S. Windecker, A. Remondino, and F.R. Eberli Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization N Engl J Med 353 2005 653 662
2. A. Schömig, A. Dibra, and S. Windecker A meta-analysis of 16 randomized trials of sirolimus-eluting stents in patients with coronary artery disease J Am Coll Cardiol 50 2007 1373 1380
3. K. Nishihira, K. Shibata, and T. Ishikawa Repeated sirolimus-eluting stent implantation to treat sirolimus-eluting stent and bare-metal stent restenosis Circ J 74 2010 2329 2333
4. A. Abizaid, J.R. Costa Jr., and A. Banning The sirolimus-eluting cypher select coronary stent for the treatment of bare-metal and drug-eluting stent restenosis. Insights from the e-SELECT (Multicenter Post-Market Surveillance) Registry J Am Coll Cardiol Interv 5 2012 64 71
5. R. Mehran, G. Dangas, and A.S. Abizaid Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome Circulation 100 1999 1872 1878
6. D.E. Cutlip, S. Windecker, and R. Mehran Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351
7. G.W. Stone, A. Rizvi, and W. Newman Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease N Engl J Med 362 2010 1663 1674
8. R.A. Byrne, A. Kastrati, and S. Massberg Biodegradable polymer versus permanent polymer drug-eluting stents and everolimus- versus sirolimus-eluting stents in patients with coronary artery disease: 3-year outcomes from a randomized clinical trial J Am Coll Cardiol 58 2011 1325 1331
9. M. Almalla, J.W. Schröder, V. Pross, E. Stegemann, N. Marx, and R. Hoffmann Everolimus-eluting versus paclitaxel-eluting stents for treatment of bare metal stent restenosis Am J Cardiol 108 2011 518 522